Table 6.
Staged renal insufficiency stratified by the presence of clinical manifestation of cardiac disorder (nonspecific sinuses, left ventricular hypertrophy, and heart enlargement).
| Parameter | Equation | Condition | Stage 1 | Stage 2 | Stage 3 | Stage 4 | p value |
|---|---|---|---|---|---|---|---|
| Left ventricular hypertrophy (electrocardiograph) | 4v-MDRD | Absent | 66 (74.12) | 17 (19.10) | 6 (6.74) | 0 (0.00) | p < 0.0001 |
| Present | 54 (35.53) | 72 (47.37) | 26 (17.11) | 0 (0.00) | |||
| CG | Absent | 68 (76.40) | 12 (13.48) | 9 (10.11) | 0 (0.00) | p < 0.0001 | |
| Present | 68 (44.74) | 53 (34.87) | 30 (19.74) | 1 (0.67) | |||
| CKD-EPI | Absent | 66 (74.16) | 17 (19.10) | 6 (6.74) | 0 (0.00) | p < 0.0001 | |
| Present | 51 (33.55) | 72 (47.37) | 29 (19.08) | 0 (0.00) | |||
|
| |||||||
| Left ventricular hypertrophy (echocardiograph) | 4v-MDRD | Absent | 62 (76.54) | 16 (19.75) | 3 (3.70) | 0 (0.00) | p < 0.0001 |
| Present | 58 (36.25) | 73 (45.63) | 29 (18.13) | 0 (0.00) | |||
| CG | Absent | 65 (80.25) | 12 (14.83) | 4 (4.94) | 0 (0.00) | p < 0.0001 | |
| Present | 71 (44.38) | 53 (33.13) | 35 (21.88) | 1 (0.63) | |||
| CKD-EPI | Absent | 64 (79.00) | 14 (17.30) | 3 (3.70) | 0 (0.00) | p < 0.0001 | |
| Present | 53 (33.10) | 75 (46.90) | 32 (20.00) | 0 (0.00) | |||
|
| |||||||
| Cardiomegaly (X-ray) | 4v-MDRD | Absent | 74 (71.80) | 21 (20.40) | 8 (7.80) | 0 (0.00) | p < 0.0001 |
| Present | 46 (33.30) | 68 (49.30) | 24 (17.40) | 0 (0.00) | |||
| CG | Absent | 79 (76.70) | 18 (17.48) | 6 (5.83) | 0 (0.00) | p < 0.0001 | |
| Present | 57 (41.30) | 47 (34.06) | 33 (23.91) | 1 (0.73) | |||
| CKD-EPI | Absent | 64 (79.00) | 14 (17.30) | 3 (3.70) | 0 (0.00) | p < 0.0001 | |
| Present | 53 (33.10) | 75 (46.90) | 32 (20.00) | 0 (0.00) | |||
Data is presented as figure with percentage in parenthesis. 4v-MDRD: four-variable modification of diet in renal disease, CG: Cockcroft-Gault, and CKD-EPI: chronic kidney disease epidemiology collaboration equation.